I. Introduction
A new website has just been launched with the URL of www.celebritygenetics.com (“Celebrity Genetics”).1 Designed to appeal to the public’s seemingly insatiable appetite for information about celebrities,2 Celebrity Genetics sells genetic information about hundreds of entertainers, politicians, athletes, and other public figures. For a fee ranging from twenty dollars to several hundred dollars, individuals and commercial publishers (such as blogs and tabloids) can purchase genetic information about selected celebrities, such as relatedness to other celebrities (e.g., paternity); ancestral place of origin; cognitive ability; behavioral genetic profile (e.g., genetic contribution to sexual orientation, propensity to addiction, and degree of risk-seeking behavior); and predisposition to various illnesses.
The analysis of celebrity DNA samples is merely the latest application of new genetic technologies to test individuals without consent and for purposes other than health care.3 In the late 1980s, law enforcement officials began matching DNA left at crime scenes with samples donated to police by suspects, often in “DNA dragnets,” to identify serial murderers and rapists.4 Soon thereafter, law enforcement officers began obtaining DNA samples from suspects without consent and, in some cases, surreptitiously or by ruse from licked envelopes and stamps,5 soft drink cans,6 cigarette butts,7 chewing gum,8 and other objects.9
At about the same time, fathers with child support obligations who were suspicious of their child’s paternity were urged by billboard advertising and other mass marketing techniques to have DNA testing of themselves and their children (without the knowledge or consent of the child’s mother) to confirm or rebut their paternity.10 At first, the “doubtful dads” brought their children to genetic testing laboratories for the sample collection.11 Soon thereafter, online entrepreneurs began advertising paternity testing services using home-collection kits involving cheek swabs, which captured buccal cells in saliva.12
It was not long before an “anything goes” atmosphere permeated the Internet world of DNA-based parentage testing—and the trend has continued unabated. For a fee, virtually any source of DNA that can be tested will be tested—with or without consent. For example, one web-based laboratory13 offers a list of items it will test and the cost for each, including the following: chewed chewing gum ($240—Wrigley Juicy Fruit is claimed to work best); cigarette butts ($240—six should be sent); hard candy ($300—well-sucked lollipops are preferred); used condoms ($300); semen stains on clothing ($300);14 used tampons or feminine pads ($240); sweaty hats or ball caps ($300); “hocked loogies” ($300—best if uninfected); plucked hair ($240—three to ten strands); Q-tips with ear wax ($300—up to three swabs); snotty Kleenex ($300—best if full of mucus); and fecal matter ($360—must be frozen immediately).15
Celebrity Genetics thus entered an already sleazy world of covert genetic analysis to offer yet another unsavory DNA testing service. Unlike testing for personal use, however, Celebrity Genetics assumes that the test results will generate widespread commercial interest. Celebrity Genetics’ business depends on maintaining interest in the genetic information of celebrities and replenishing the supply of DNA for analysis, and the company uses an ingenious method to do both. Celebrity Genetics’ website has a section called “DNA Wanted.” Hundreds of celebrities are listed, each with a price or bounty for the first collector who submits a sample of the celebrity’s DNA. As a result, Celebrity Genetics has created an army of thousands of amateur “gene-arazzi” from all over the world who hope to (and in some cases, do) make money and achieve fleeting notoriety by obtaining and selling the DNA of listed celebrities. The Celebrity Genetics website does not specify the method of sample collection; it merely lists some suitable items for DNA testing, such as used chewing gum and cigarette butts.
In attempting to verify that the DNA sample submitted is that of the celebrity claimed, the collector uses a cell phone or camera to obtain a digital image of the celebrity using a particular object (for example, a napkin in a restaurant). Then the collector places the object in a special mailing envelope sold by Celebrity Genetics to the DNA sleuths. Once received, the DNA is analyzed and the results are offered for sale on the Celebrity Genetics website.16 In their frenzy to obtain samples, DNA collectors in Hollywood, Cannes, Monte Carlo, Washington, Beijing, and other places have scavenged through the trash cans of political candidates, movie stars, judicial nominees, and Olympic athletes; pilfered napkins and utensils from chic restaurants; bribed bartenders and chambermaids for used glasses, towels, and linens; stolen dirty clothes from laundries and dry cleaners; and vandalized barber and beauty shops.17 Privacy advocates and various celebrities have voiced concerns about the intrusions and disruptions in obtaining the DNA, and in publication of the test results.18
Are Celebrity Genetics and its inevitable “copy-cat” websites merely the harmless, twenty-first century versions of gossip columns and tabloid photographs from an earlier era? Or does this phenomenon represent an insidious infringement on the rights of individuals to be let alone and to prevent their intimate personal health information from being involuntarily generated, publicized, and exploited?19
This Article considers whether individuals—celebrity or not—have or should have constitutional, statutory, or common law rights to prevent the seizure, analysis, and publication of genetic information without their consent. Part II of the Article discusses the constitutional issues associated with taking and analyzing objects containing DNA, including abandoned property. Part III considers the applicability of common law actions for invasion of privacy and conversion. Next, Part IV analyzes state genetic privacy laws. Part V assesses the policy options for dealing with this emerging issue, including illustrative federal and foreign laws, and presents a preliminary legislative agenda. Finally, Part VI concludes by observing what a future world without genetic privacy would be like.
II. Constitutional Law
Constitutional law is a logical starting point for analyzing privacy law because the Constitution has long been the source of rights involving individual autonomy, marriage, procreation, and medical privacy.20 Although constitutional law is unlikely to provide a remedy in cases of genetic stalking by private parties, constitutional case law may be relevant in developing legislative and common law approaches to the issue.21 In general, the basic constitutional issue is whether individuals have a reasonable expectation of privacy in an object containing DNA so as to implicate the protections of the Fourth Amendment,22 the Fourteenth Amendment,23 or comparable provisions of state constitutions.24
The cases with facts closest to genetic stalking involve police seizing abandoned property and using it as evidence in a criminal prosecution. In the leading case of California v. Greenwood, a police investigator, suspecting that an individual was engaged in drug trafficking, asked the suspect’s regular municipal trash collector to pick up the plastic trash bags that the suspect left on the curb in front of his house and give them to the police without mixing them with other trash bags.25 The trash collector gave the police the suspect’s trash bags every week for at least two months.26 No warrant was obtained by the police to search the bags,27 which contained “items indicative of narcotics use.”28 The police used this evidence to obtain warrants to search the house, where they found cocaine and hashish.29
In reversing the dismissal of the case in state court, the Supreme Court upheld the search and seizure under the Fourth Amendment.30 The Court, in an opinion by Justice White, held that the defendants did not have a reasonable expectation of privacy in their garbage.31 “It is common knowledge that plastic garbage bags left on or at the side of a public street are readily accessible to animals, children, scavengers, snoops, and other members of the public.”32 The Court included a footnote about the practice of some tabloid journalists of combing through the garbage outside the home of Secretary of State Henry Kissinger.33 In dissent, Justice Brennan asserted that because “[s]crutiny of another’s trash is contrary to commonly accepted notions of civilized behavior,” it is reasonable to expect that one’s garbage will not be subject to search.34 “The mere possibility that unwelcome meddlers might open and rummage through the containers does not negate the expectation of privacy in their contents any more than the possibility of a burglary negates an expectation of privacy in the home ….”35
The holding in Greenwood, however, is not limited to trash; it is part of a more general proposition that individuals have no reasonable expectation of privacy in abandoned property.36 For example, in Abel v. United States, an FBI agent searched a hotel room after a suspect had paid his bill and vacated the room.37 There, in a wastepaper basket, the agent found a “cipher pad” used in espionage.38 The Supreme Court held that the evidence was lawfully seized because the defendant had abandoned it.39
In contrast to Supreme Court precedent, some state courts have interpreted their state constitutions to be more protective of the right of privacy in abandoned property. For example, in State v. Goss,40 the Supreme Court of New Hampshire considered a case with facts virtually identical to Greenwood. The police seized and searched the trash of an individual suspected of growing marijuana in his house.41 The trash was in black plastic bags left on a driveway about three feet from the road on a regular trash pick-up day.42 The bags contained “a wire scraper on which there was charred material that tested positive for presumptive marijuana presence.”43 Based on this evidence, the police obtained a warrant to search the defendant’s house, where they found marijuana.44 The court expressly declined to apply Greenwood to New Hampshire’s state constitutional prohibition against unreasonable searches and seizures because it did “not believe that conveying trash to a trash collector for disposal renders an expectation of privacy in the trash unreasonable.”45 New Hampshire thereby joined a minority of courts in holding that there is a reasonable expectation of privacy in trash left for collection by regular trash collectors.46
Constitutional case law is not directly applicable to the issue of genetic stalking. First, there is the matter of state (or governmental) action. Federal constitutional requirements under the Fourth and Fourteenth Amendments are relevant only when the government is conducting the search and seizure.47 Second, there are six states with constitutional privacy protections applicable to both public and private actors.48 Although these states prohibit unreasonable searches and seizures by both governmental and private actors,49 it is not clear whether taking and analyzing abandoned property would be considered unreasonable in these states.50 Finally, there is the matter of fashioning an appropriate remedy. In genetic stalking, often the person seizing the property will be the least easily identifiable and least solvent party. Consequently, aggrieved individuals and policy makers should look beyond constitutional search and seizure law to address the issue of nonconsensual genetic testing and publication of the results.
III. Common Law
A. Invasion of Privacy
In 1890, two young law partners from Boston, Samuel D. Warren and Louis D. Brandeis, published a seminal article on the right to privacy at common law.51 According to most historians, the impetus for the article was Warren’s concern about the allegedly intrusive social reporting of the Boston press, but it is not clear what, if any, specific stories aroused his ire.52 Brandeis collaborated with Warren to write their influential and legendary law review article, The Right to Privacy.53 Although it was inspired by perceived abuses by the press, Warren and Brandeis argued more broadly in favor of a comprehensive common law right of individuals to be free from unwanted and unreasonable intrusions of their “inviolate personality.”54
Warren and Brandeis expanded on Judge Thomas M. Cooley’s notion of privacy as “the right ‘to be let alone.’”55 They proposed a general legal principle of protecting “the privacy of private life”56 and urged creating a cause of action to redress “the more flagrant breaches of decency and propriety.”57 They concluded their article by observing the irony between the different standards used by the law in dealing with public and private interferences with peaceful habitation: “The common law has always recognized a man’s house as his castle, impregnable, often, even to its own officers engaged in the execution of its commands. Shall the courts thus close the front entrance to constituted authority, and open wide the back door to idle or prurient curiosity?”58
Despite its well-deserved acclaim in the academic literature, the Warren and Brandeis article did not immediately translate into a concrete common law doctrine that could be invoked to redress private wrongs.59 Beginning in the 1930s, courts in several states began to recognize a right of privacy, but the contours of the right were not well defined.60 The task of developing a cohesive doctrine fell to William L. Prosser who, in a famous law review article in 1960, proposed that the common law right to privacy was actionable in tort in four discrete situations:
Intrusion upon the plaintiff’s seclusion or solitude, or into his private affairs.
Public disclosure of embarrassing private facts about the plaintiff.
Publicity which places the plaintiff in a false light in the public eye.
Appropriation, for the defendant’s advantage, of the plaintiff’s name or likeness.61
Some scholars have argued that, in carving out limited categories of protected interests, Prosser engaged in reductionism and oversimplification of the human dignity embodied in the right to privacy.62 Nevertheless, the Restatement (Second) of Torts adopted Prosser’s classifications,63 and the limited, categorical approach to common law torts for invasion of privacy steadily gained widespread acceptance in the United States.64
All four of the prototypical common law invasions of privacy are implicated by genetic stalking and voyeurism, but not every jurisdiction recognizes all four types of invasion of privacy. Even in jurisdictions that do, it is not clear that courts would be prepared to apply invasion of privacy to the acts of obtaining, analyzing, and disclosing the genetic information of celebrities or “ordinary” individuals without their consent.
1. Intrusion upon Seclusion
The Restatement (Second) of Torts defines the tort of intrusion upon seclusion as follows: “One who intentionally intrudes, physically or otherwise, upon the solitude or seclusion of another or his private affairs or concerns, is subject to liability to the other for invasion of his privacy, if the intrusion would be highly offensive to a reasonable person.”65 The intrusion may be physical (as by entering a home without permission), electronic (as by wiretapping or electronically eavesdropping), or may occur by prying into private affairs (as by unauthorized scrutiny of an individual’s bank records).66 Although the Restatement provides that no physical intrusion is required,67 some courts have held to the contrary.68 According to one formulation, “[p]eeping and eavesdropping are prime examples” of intrusion.69 Two key factors used by the courts in determining the unreasonableness of the intrusion are the method used and the purpose of the defendant’s conduct.70
In the context of genetic stalking,71 there are four important considerations. First, it is necessary to determine the act of intrusion. If there has not been any trespass to property, trespass to chattel, or conversion in the acquisition of the object to be tested, it would be more difficult to argue that there has been intrusion upon seclusion. Thus, where an interested party merely took a piece of abandoned property from a public place (e.g., a piece of used gum or a cigarette butt from a sidewalk), courts are likely to hold that there has not been any intrusion into an individual’s legally protectable interest. If there is an intrusion in this scenario, it must be from the act of performing DNA testing on the object without consent.72 Such a “dignitary” as opposed to “property” view of intrusion,73 independent of any physical intrusion or the widespread disclosure of the test results, is based on the sensitive nature of the information revealed by the DNA testing. Although there is no case law in support of this approach, the courts have yet to be presented with facts involving genetic stalking.
Second, the courts have been reluctant to find an intrusion upon seclusion for conduct occurring in a public place because an individual has no reasonable expectation of privacy in public places.74 The reluctance to find liability for intrusion in public places, however, is not absolute. Where special factors exist, recovery may be warranted, such as where a newspaper published a photograph of a woman who was exiting the fun house at a county fair and her skirt was blown up by air jets under the platform,75 where there was overzealous and unreasonably intrusive surveillance including wiretapping,76 or where there was persistent surveillance amounting to harassment.77
Third, in the relatively few cases decided thus far, the courts have not developed a consistent doctrine for when medical testing beyond the bounds of consent constitutes intrusion upon seclusion. For example, a Pennsylvania court held that no intrusion upon seclusion occurred when a physician conducting a pre-marital blood test performed an HIV test without consent and retained the results.78 The court held that because there was consent to draw the blood, there was no “invasion of bodily integrity.”79 By contrast, a Colorado court held that performing an unauthorized HIV test on a student’s blood sample submitted for rubella testing, and then reporting the positive HIV test result to the state health department, constituted intrusion.80 Significantly for the issue of genetic stalking, the court said that extracting the blood and testing the blood were separate acts for purposes of intrusion.81
Fourth, to be actionable, the intrusion must be highly offensive to a reasonable person. In the case of genetic stalking, this would seem to be the least difficult hurdle for a plaintiff. The defendants’ acts are motivated by their own pecuniary interests and, at a minimum, demonstrate an indifference to the harm caused by the disclosures.
2. Public Disclosure of Private Facts
Public disclosure of private facts is what led Warren and Brandeis to propose the right to privacy, yet it has proven to be the most difficult of the four privacy torts to apply.82 Public disclosure of private facts is the essence of genetic stalking and surreptitious genetic testing, but it is not clear whether the conduct is actionable in tort. According to the Restatement (Second) of Torts, public disclosure of private facts consists of the following elements: (1) disclosure to the public or a large number of persons; (2) of a fact that is private in nature; (3) which would be highly offensive to a reasonable person; and (4) is not of legitimate concern to the public.83 The disclosure of information about celebrities could potentially involve all four elements.
The first element, widespread publication, is easily satisfied by the distribution of the information in any form of mass media, such as by print, broadcast, or through the Internet. Even oral communication may be sufficient if there are enough listeners.84 There are several cases involving the disclosure of private information to co-workers. In general, courts hold that disclosure of private information to a limited number of current or former co-workers is not sufficient disclosure,85 but authority exists to the contrary.86 Some of these cases turn on whether the employer had a conditional privilege to disclose the information,87 a fact that is irrelevant in the context of nonconsensual publication of genetic information.
Second, the fact disclosed must be of a private nature. Examples in the Restatement are sexual relations; family quarrels; unpleasant, disgraceful, or humiliating illnesses; and intimate personal letters.88 Several cases involving the disclosure of an individual’s HIV-positive status have held that such information, with its attendant stigma, is private in nature.89 Unlike HIV-positive status, however, genetic information is not necessarily “unpleasant[,] … disgraceful[,]… or humiliating” as used in the Restatement. For example, genetic information might confirm the paternity of a celebrity father and child; indicate that an individual is not genetically predisposed to cancer, Alzheimer’s disease, or some other serious illness; or indicate that a celebrity’s ancestral origins coincide with his or her public assertions. Despite the fact that the information is, in a sense, “favorable” to the individual, it is nevertheless of a private nature, and the purpose of the tort is to retain for the individual the autonomy to decide whether to undergo genetic testing and, if so, whether to disclose the results. Therefore, disclosure of any results of nonconsensual genetic testing should be actionable, but would not necessarily be under current standards.
Another aspect of private information is that it must not be within the realm of public knowledge. If the information is a matter of public record90 or otherwise widely known,91 then even highly sensitive information cannot be considered private. In the context of celebrities, with so much information available about them—some disclosed by them or their agents for their own purposes—the range of topics considered private might be considerably narrower than for other individuals.
Third, the disclosure must be highly offensive to a reasonable person. An often-cited, but frequently criticized, case is Sidis v. F-R Publishing Corp.92 A former child mathematics prodigy, who had become a recluse, was tracked down and interviewed about his current whereabouts and activities.93 The information was published in a popular magazine.94 The court held that there was no liability because, despite being highly offensive to the plaintiff, publication of the information was not considered highly offensive to a reasonable person.95 The result may be questioned as inappropriately applying an objective standard when the wrongdoer already knew of the individual’s heightened sensitivity.96 An alternative basis for finding liability in the case is simply that the information was wrongfully obtained by deceit.97
Fourth, the matter must not be a legitimate concern of the public. There is a clash between the interests of privacy and First Amendment protections for freedom of expression. In Sipple v. Chronicle Publishing Co., the plaintiff, a private citizen, became famous when he acted to prevent the shooting of then-President Ford.98 Two days later, a newspaper columnist revealed that the plaintiff was gay, resulting in substantial emotional distress.99 The plaintiff’s subsequent action for invasion of privacy was unsuccessful, in part, because his sexual orientation was considered “newsworthy.”100 The court’s analysis and its implications are troubling. Because there was no connection between the reason for the plaintiff’s newsworthiness and his sexual orientation, Sipple suggests that any information about someone in the public eye, no matter how fleeting, might be considered “newsworthy.”
Another case involving newsworthiness is Gilbert v. Medical Economics Co.101 The defendant magazine published an extremely critical article about an anesthesiologist, which included her picture and name, as well as personal facts about her psychiatric history and marital life.102 In an action for invasion of privacy, the court held that the plaintiff’s personal information was newsworthy because of the close nexus between the plaintiff’s personal problems and the underlying malpractice issues in the story, which were matters of public concern.103
Because of the difficulty in drawing lines between newsworthy information and disclosures that invade the privacy of the individual, some states have rejected any actions for public disclosure of private facts.104
3. False Light
The Restatement (Second) of Torts defines false light invasion of privacy as follows:
One who gives publicity to a matter concerning another that places the other before the public in a false light is subject to liability to the other for the invasion of his privacy, if
(a) the false light in which the other was placed would be highly offensive to a reasonable person, and
(b) the actor had knowledge of or acted in reckless disregard as to the falsity of the publicized matter and the false light in which the other would be placed.105
The injury in a false light claim is the mental distress resulting from an invasion of the individual’s privacy; by contrast, in defamation the harm is to the individual’s reputation.106 Thus, theoretically, it is easier for a plaintiff to prove false light than defamation because the plaintiff in a false light case need only prove that the communication was false and offensive, rather than defamatory.107 As with defamation, however, the defenses of truthfulness of the statement, consent, the expression of opinion by the defendant, and privileged communication will preclude liability.108
The Supreme Court added a constitutional dimension to the tort of false light invasion of privacy with its decision in Time, Inc. v. Hill.109 The Court held that in false light cases, as in defamation cases,110 if the plaintiff is a public official or public figure, the false light statement is only actionable if it was published with knowledge of falsity or a reckless disregard for the truth.111 The actions of an agent, such as a reporter, may be attributable to a principal, including a newspaper.112
False light invasion of privacy might be implicated in genetic stalking cases, but the facts would have to be exceptional, especially because the plaintiff, as a celebrity, would be a public figure. Liability is possible if the defendant published the results of a genetic test and falsely attributed the results to the plaintiff when the defendant knew they were not the plaintiff’s test results or published the results with a reckless disregard for the truth.113 Other possible bases of liability are publishing test results generated by a laboratory known to produce erroneous findings and reporting associations between genetic test results and health conditions known not to be based on scientific evidence. Because of the nature of the defendant’s conduct required to establish false light invasion of privacy, if this cause of action were used in the context of genetic stalking, it would likely be part of a series of tort claims rather than a single basis of liability.
4. Appropriation of Name or Likeness
The Restatement (Second) of Torts provides a cause of action for invasion of privacy based on appropriation of an individual’s name or likeness. “One who appropriates to his own use or benefit the name or likeness of another is subject to liability to the other for invasion of his privacy.”114 Typical cases have involved the use of an individual’s photograph in advertising without permission.115 One who sells another individual’s DNA profile without permission would clearly seem to be benefiting from “the reputation, prestige, social or commercial standing, public interest or other values of the plaintiff’s name or likeness.”116 The only issue is whether the results of a DNA test would constitute an individual’s “name or likeness.” Not surprisingly, there are no cases directly on point.117
In Moore v. Regents of the University of California, John Moore, a resident of Seattle, was treated for hairy-cell leukemia by Dr. David W. Golde at the University of California-Los Angeles (UCLA) Medical Center.118 Following a surgical splenectomy as part of his treatment, portions of Moore’s excised spleen were used by Dr. Golde and his research colleagues to develop a cell line from Moore’s T-lymphocytes.119 UCLA applied for, and was granted, a patent on the cell line, which listed Dr. Golde and a colleague as inventors.120 Although the invention was expected to have substantial commercial value, no royalties or profits were ever generated and the defendants only received an initial payment from the commercial interests.121 Nevertheless, neither Dr. Golde nor anyone else at UCLA informed Moore before surgery, after surgery, or during three follow-up visits—suggested by Dr. Golde, during which additional blood and other biological specimens were obtained—that UCLA intended to use Moore’s biological material for research or commercial purposes.122
When Moore learned of the use of his cell lines without his permission, he sued the defendants under various causes of action.123 In rejecting Moore’s claim for appropriation of name or likeness, the California Supreme Court held that the appropriated material must be “unique” to the plaintiff, and the court stated that the lymphokines used by the defendants are of the same basic molecular structure in all human beings.124 Such an argument is hard to square with either the science or the facts, because it was precisely the uniqueness of the cell line derived from John Moore that purportedly made it so valuable. Similarly, even though the DNA of any human is comprised of the same four nucleotides, the order of the nucleotide base pairs is unique in every human, and DNA analyses indicate, or at least suggest, certain biological characteristics of the individual whose DNA is analyzed.125
Some states have codified the common law tort of appropriation of name or likeness to prohibit the use of a person’s photograph or name for commercial purposes without express consent,126 although the statutory approach does not necessarily translate into greater privacy protection than the common law. In Mendonsa v. Time Inc., a statutory claim was brought under New York law by the sailor in the famous Life magazine photo depicting him kissing a nurse in Times Square on V-J Day in 1945.127 In 1987, Life offered to sell copies of the photograph for $1600 each without offering any compensation to the sailor, whose identity was known.128 The court held that, although the initial publication in 1945 was newsworthy and not for commercial purposes, the subsequent publication was for commercial purposes in violation of the statute.129 It is not clear whether statutorily-based claims for appropriation of DNA information would be greeted with greater judicial solicitude than common law claims. Nevertheless, the existence of state statutes suggests a legislative intent to protect celebrities and others from commercial exploitation of their public persona.
B. Conversion
Traditionally, individuals have not been concerned about what happens to traces of their saliva or other biological material left behind on a subsequently seized object. They have been concerned about the information that can be discovered through genetic or other scientific analysis of the biological material. Conversion is a property tort and, to be actionable, the plaintiff must have an ownership interest in the property converted.130 With abandoned waste material, it may be difficult to assert a property interest in the object taken, such as a discarded cigarette butt or soft drink can. Alternatively, even if an individual does not have a property interest in the abandoned object containing the biological material, an individual might assert a property interest in the information contained in the specimen. If so, then another party’s intentional exercise of dominion over the specimen containing the information would constitute the tort of conversion.131 In the few cases that address the issue, the courts were not receptive to either theory.
The leading case on conversion of human biological material is Moore, discussed in the previous section. Another of Moore’s claims was based on conversion.132 In analyzing this cause of action, the California Supreme Court considered whether Moore retained an ownership interest in his cells after his possession of the cells ended.133 The court observed that no reported judicial decision supported Moore’s claim, and furthermore, that a California statute seemed to limit a patient’s continuing interest in excised cells.134 The court also emphasized that the patent was not issued on the excised tissue, per se, but on the cell line developed from the tissue, and that public policy supported the development of materials for biomedical research.135 As the court stated: “[t]he extension of conversion law into this area will hinder research by restricting access to the necessary raw materials.”136
A similar issue was raised in Greenberg v. Miami Children’s Hospital Research Institute, Inc.137 Plaintiffs, who were parents of children with Canavan disease,138 gave money and tissue samples to a researcher to discover the genetic basis of the Disorder.139 The researcher successfully isolated the gene responsible for Canavan disease.140 Without informing the plaintiffs, the researcher’s institution patented the gene and licensed it to a genetic test developer.141 The plaintiffs sued on various legal theories, including conversion.142 The court held that the plaintiffs failed to state a claim for conversion.143 It cited Moore with approval and noted that under Florida law “the property right in blood and tissue samples … evaporates once the sample is voluntarily given to a third party.”144
In considering how these cases might affect an action for conversion based on genetic stalking, there are three distinguishing characteristics. First, in both Moore and Greenberg, the samples were voluntarily given to the researchers, albeit not with the intent to authorize the subsequent uses.145 Genetic stalking cases could involve either abandoned property (e.g., discarded chewing gum) or stolen property (e.g., a napkin taken from a restaurant). It is not clear if the method of acquisition of the specimen would influence the outcome of an action for conversion because the basis of the action is not conversion of the object containing the DNA, but obtaining and using the information revealed by the DNA. Second, Moore and Greenberg explicitly relied on the public policy in favor of medical research.146 No such public interest is ordinarily implicated in analyzing biologically “unexceptional” DNA. There might be a public interest in learning the genetic predisposition to illness of a candidate for high public office, but in typical cases courts relying on public policy would likely find that it favors protecting genetic information from unwanted disclosure. Third, in Moore and Greenberg, the specimens had value because they formed the basis of a cell line or indicated the presence of a genetic marker.147 A court might decide that the traces of saliva or other body fluids acquired solely for analysis have no value in themselves, but only as the source of information. Thus, they might conclude that nothing of value was converted.148 Based on existing case law, conversion is unlikely to afford a viable cause of action for the unauthorized taking of an object for genetic testing and publication of the results.
IV. State Genetic Privacy Laws
Beginning in the 1990s, several states enacted some form of genetic privacy law,149 often as part of a legislative package including prohibitions on genetic discrimination in health insurance, employment, or both. Among other things, these laws require consent (often written, informed consent) before genetic testing is performed, before access is granted to genetic information, and before genetic information is retained or disclosed.150 The laws usually provide for specific penalties for violations.151 As of 2009, there were twelve states with laws requiring consent before performing genetic testing.152 The laws all contain several exceptions which vary by state but generally include genetic testing for law enforcement, newborn screening, paternity determinations, and other publicly acceptable purposes.
In reviewing these laws, it is doubtful that any of them would apply to genetic stalking and surreptitious genetic testing. To begin with, the laws in three states only apply to health care providers or physicians.153 In another, the law only applies to insurance companies.154 Of the states with laws of general applicability, one applies only to “predictive” genetic testing, which would characterize a test indicating an individual’s risk of illness, but would not apply to a genetic analysis of parentage, ethnic origins, or other tests likely to be performed in the context of genetic stalking.155 Four states prohibit the genetic testing of a biological sample “taken from an individual,”156 a “sample,”157 or “bodily materials” of an individual,158 all of which might not apply to genetic testing of an abandoned item. As to the remaining three states159 with the most general or vague prohibitions on nonconsensual genetic testing, there is no indication that the laws were intended to address the issue of genetic stalking or surreptitious genetic testing.
V. Policy Options
New DNA technology creates great challenges for protecting privacy. Every human sheds DNA constantly in hair and skin cells; we also leave traces of DNA (e.g., in saliva and perspiration) on objects used in daily life. Does the ubiquity of DNA and the ease of obtaining, analyzing, and publishing the results of genetic testing make it futile to attempt to control genetic stalking and voyeurism? Or, are the privacy interests so fundamental and the potential harms so substantial to all individuals—not just celebrities—that a comprehensive regime of legal regulation should be developed and implemented immediately to prohibit nonconsensual genetic testing?160
The range of possible answers to these questions is illustrated by quotes from two highly diverse sources. On one side, Justice Brandeis, in his famous dissent in Olmstead v. United States, rejected the Supreme Court majority’s view that the Fourth Amendment did not extend to wiretapping because electronic communications were unknown when the Fourth Amendment was adopted.161 He wrote: “Time works changes, brings into existence new conditions and purposes. Therefore a principle to be vital must be capable of wider application than the mischief which gave it birth.”162 According to Brandeis, privacy is such a fundamental element of civilized society that legal doctrines should be adapted to respond to new technological developments.163 The opposite view is captured succinctly by the often-quoted statement of Scott McNealy, Chief Executive Officer of Sun Microsystems, who responded to consumer privacy concerns about new technology by stating: “You have zero privacy anyway. Get over it.”164
A. Additional Sources of Public Policy
Sections II–IV discussed the applicability and adequacy of constitutional law, tort law, and state genetic privacy laws in preventing genetic stalking and remedying its harms. In formulating public policy, it is also valuable to consider instructive legislative responses to emerging privacy concerns.
Genome sequencing, digital communications, the Internet, and other technologies complicate the task of protecting genetic privacy. Nevertheless, the following three laws enacted since 2003 strongly suggest that measures to prohibit genetic stalking and voyeurism could receive popular and political support. Collectively, these laws show the inclination of legislatures to respond to new privacy threats, even if the response is slow in coming and incomplete in coverage.
1. Genetic Information Nondiscrimination Act (GINA)
The Genetic Information Nondiscrimination Act of 2008 (GINA)165 was enacted after a difficult, thirteen-year battle in Congress.166 GINA prohibits discrimination in health insurance and employment on the basis of genetic information, defined as information about an individual’s genetic tests, the genetic tests of family members, or the occurrence of a disease in family members of the individual.167 GINA prohibits health insurers and employers from requiring genetic testing or using an individual’s genetically-enhanced risk of illness to discriminate in health insurance coverage or cost, or in any terms and conditions of employment.168
Despite the lack of many documented incidents of genetic discrimination,169 GINA was enacted because numerous individuals at risk of genetic disorders declined testing out of fear of the consequences.170 Thus, by prohibiting certain uses of genetic information generated by the tests, in theory, at-risk individuals would be more willing to undergo potentially beneficial genetic testing.171 The congressional findings section of GINA states that federal legislation “is necessary to fully protect the public from discrimination and allay their concerns about the potential for discrimination, thereby allowing individuals to take advantage of genetic testing, new technologies, and new therapies.”172
It is unlikely that GINA will have its desired effects. The law is notoriously limited in scope.173 It does not apply to life insurance, disability insurance, or long-term care insurance.174 Significantly, GINA only applies to individuals who are asymptomatic.175 Thus, it would not prevent a health insurance company from declining to renew or substantially increasing the rates for an individual health insurance policy after an individual becomes ill, even if the individual is affected by the condition for which he or she was at a genetically increased risk.176 GINA explicitly provides that the statute does not apply if there has been a “manifestation” of a disease or disorder,177 but the term is not defined. It is not clear what effect increasingly sophisticated biomarkers that measure presymptomatic biological changes will have on statutory coverage.178
GINA is not totally without value.179 It prohibits discrimination against individuals at increased risk of a genetic-related condition, and many such individuals will never develop the condition despite their increased risk. GINA also is important for policy reasons. It is the first federal law expressly intended to prevent discrimination based on genotype.180 It is also the first federal law exclusively intended to ameliorate the negative consequences of new genetic technologies.
2. Video Voyeurism Prevention Act
The federal Video Voyeurism Prevention Act of 2003 amended the federal criminal code to prohibit a person within the territorial jurisdiction of the United States from intentionally capturing an image of a private area of an individual’s unclothed or “undergarment clad” body without the individual’s consent under circumstances in which the individual has a reasonable expectation of privacy.181 An individual convicted of such an offense is subject to a fine of up to $100,000, up to one year imprisonment, or both.182
According to the House Report on the law, “video voyeurism” was becoming a growing privacy concern because of the “development of small, concealed cameras and cell phone cameras, along with the instantaneous distribution capabilities of the Internet.”183 Many states lacked legislation making such conduct unlawful.184 The federal law was designed to protect a reasonable expectation of privacy on federal land, such as national parks and federal buildings,185 as well as serving as model legislation for states that had not yet enacted their own laws.186
The video voyeurism law has no direct relevance to genetic stalking, but it is instructive. Congress demonstrated its willingness to enact legislation to protect the reasonable expectation of privacy of individuals from surreptitious, intrusive conduct facilitated by modern technology, including the use of the Internet to broadcast private images. On the other hand, Congress was unwilling to enact a federal law of general applicability beyond federal property.
3. Human Tissue Act (United Kingdom)
The United Kingdom’s Human Tissue Act of 2004 is a long, detailed, and comprehensive statute regulating human organ transplantation and the collection, analysis, storage, and use of human tissue.187 The law was enacted in response to reports of abuses at certain hospitals where the organs and tissue of children who had died were removed, stored, and used without proper consent.188 The law supersedes earlier transplantation laws and created a system of regulation directed by the newly established Human Tissue Authority.189 The law provides for substantial criminal sanctions for violations. A person found guilty of violating the Act is subject to a fine, imprisonment for up to three years, or both.190
Although the primary purpose of the law is to deal with the use of human tissue for transplantation and research, the law prohibits any nonconsensual analysis of DNA. Section 45 makes it unlawful for any individual, without proper consent, to possess any “bodily material” with the intent to have DNA testing performed.191 There are exceptions for medical treatment, law enforcement, research, and other uses.192
The inclusion of Section 45 is a direct result of concerns about genetic stalking. In 2002, there were press reports about an alleged plot to steal hair from Prince Harry and perform surreptitious genetic testing.193 The purpose of the plot was to determine if Major James Hewitt, with whom Princess Diana was said to have had an affair, was the father of Prince Harry rather than Prince Charles.194 Section 45 was intended to make such conduct a crime.195
Baroness Helena Kennedy, a member of the House of Lords and Chair of the Human Genetics Commission, clearly recognized that the new law bans surreptitious, nonconsensual genetic testing. She described the purpose of Section 45 in more general terms:
Until now there has been nothing to stop an unscrupulous person, perhaps a journalist or private investigator, from secretly taking an everyday object used by a public figure—like a coffee mug or a toothbrush—with the express purpose of having the person’s DNA analysed. Similarly, an employer could have secretly taken DNA samples to use for their purposes.196
The law took full effect on September 1, 2006, but as of June 2008, there had not been any prosecutions under section 45.197
B. Developing New Policies
Any comprehensive approach to regulate genetic stalking should consider the four parties involved in the process: (1) the individual stalkers who collect the DNA, (2) the laboratories analyzing the DNA, (3) the publishers of the genetic test results, and (4) the websites encouraging and facilitating the stalking.
1. The Collectors
Individuals engaged in genetic stalking could violate several statutes and common law provisions. If they were actually “stalking” the celebrities,198 this would be actionable in tort199 as well as criminal law.200 They might also be committing a separate violation in the process, such as civil or criminal trespass by entering property without permission or the crime of larceny or the tort of conversion if they stole something of value to obtain the DNA sample.
It would be of questionable utility to prosecute individuals who obtained abandoned property, even if they obtained the property with the intent to sell it or have its DNA content analyzed. Overly broad legislation could prohibit young fans from saving the used chewing gum201 or soft drink cans of rock stars or athletes. There is no reason to prohibit such collection, even with the intent to sell this “memorabilia,” any more than banning the sale of photographs of celebrities taken in public places.
If a criminal statute were enacted prohibiting the sale of an object with the intent to analyze the DNA on the object without consent, it might be very difficult to prove intent, unless the sale is to a commercial website such as Celebrity Genetics. The U.K.’s Human Tissue Act of 2004 prohibits the sale of “bodily material” with the intent to analyze DNA.202 Although such a prohibition would be valuable in the United States, other measures are also needed to outlaw genetic stalking.
2. The Laboratories
A variety of public and private bodies regulate genetic testing laboratories. Laboratories performing genetic testing for clinical purposes are regulated by the College of American Pathologists203 and the Department of Health and Human Services,204 pursuant to the Clinical Laboratories Improvement Amendments of 1988 (CLIA).205 Although about half the states have some degree of statutory authority for oversight of clinical laboratories, only California, New York, and Washington require any review of clinical validity for individual assays.206 Laboratories performing genetic testing for forensic purposes are regulated, albeit voluntarily, by the American Society of Crime Laboratory Directors and the National Forensics Science Technology Center.207 Laboratories performing genetic testing for paternity are accredited by the American Association of Blood Banks.208 Home-collection test kits for clinical use are regulated by the Food and Drug Administration.209
Despite the involvement of numerous professional and regulatory bodies, laboratories performing genetic testing for nonclinical, nonforensic, and legally inadmissible purposes currently are not subject to any regulation. New Internet-based companies performing genome-wide association studies or more limited genetic risk assessments do not submit any claims to public or private payers for reimbursement and assert that they are providing their services for informational rather than diagnostic purposes.210 These laboratories also are not covered by the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule because they do not submit claims for payment in electronic format.211 Therefore, there are no federal statutory or regulatory limits on the uses and disclosures by the laboratories of genetic information they acquire from genetic tests. Laboratories performing “curiosity” testing to assess paternity also do not require regulatory approval, although the results from an unaccredited laboratory generally are not admissible in court.212
There are no reliable figures about the number of laboratories offering various types of unregulated genetic testing services, but there are at least one hundred Internet-based genetic testing companies, and the number is growing.213 Focusing new statutes and regulations on the laboratories would be effective, at least for the laboratories located in the United States. Thus, if laboratories were prohibited from performing genetic testing without the express consent of the subject, then genetic stalking and obtaining items containing DNA would be pointless. Even as to genetic testing with consent, there are substantial concerns about analytical validity,214 clinical validity,215 clinical utility,216 misleading conclusions, and the lack of genetic counseling.
3. The Publisher
In this section, the term “publisher” is used to include any person or entity disclosing information in any form, including orally, in print, electronically, or by broadcast. In the context of genetic stalking, publication presumably will be in a form to reach numerous people. Publishers of genetic information without consent might be liable for common law invasion of privacy.217 An important but difficult question is whether a statutory restriction on publication would be feasible or constitutional under the First Amendment.
The HIPAA Privacy Rule applies only to three specific types of covered entities involved in the submission of electronic health claims data: health care providers, health plans, and health clearinghouses.218 With certain exceptions for public health, law enforcement, and other uses, the Privacy Rule prohibits uses and disclosures of protected health information beyond treatment, payment, or health care operations without the written authorization of the individual.219 To take an extreme example of HIPAA’s possible applicability to genetic stalking, suppose a hospital (a covered entity) published in its weekly newsletter for patients, staff, and others the genetic or other health information about a particular patient (e.g., a celebrity patient) without the patient’s authorization. Such conduct clearly would violate the Privacy Rule. It is unlikely that the hospital would be successful in asserting a First Amendment defense.
Suppose the HIPAA Privacy Rule were extended by Congress to be a comprehensive health privacy law, applicable to all uses and disclosures of protected health information by any individual or entity.220 Would it violate the new privacy law for a newspaper to publish genetic or other health information about a patient in the local hospital? Should it matter how the newspaper obtained the information? Should it matter what information is disclosed? Should it matter why the information is being disclosed? Should it matter if the patient is an ordinary resident of the community or an important elected official or candidate for a high political office?221
Some statutory and regulatory measures to protect the privacy of individuals from publication of their health information will withstand constitutional scrutiny.222 At some point, however, the public’s interest in having access to the information will outweigh the individual’s right to privacy and come within the protections of the First Amendment.223 Because of the difficulties in discerning and defining such a point, it is appropriate to consider the larger question of whether efforts to prevent genetic stalking and nonconsensual publication of genetic information should focus on the publishers of the information or should target other parties.
4. The Websites
Celebrity Genetics initiated the collection of the specimens, contracted to perform the genetic testing, and offered to sell the genetic test results. Thus, Celebrity Genetics is more than a content-neutral bulletin board or Internet service provider; it is a content provider.224 From a regulatory standpoint, however, it is not clear whether Celebrity Genetics is engaged in any illegal conduct. Under current law, Celebrity Genetics might be subject to civil liability for invasion of privacy,225 but criminal liability would be possible only if the website analyzed the samples in one of the twelve states that require express consent for genetic testing,226 and it is not clear that any of these state laws would apply.
There are at least four ways in which the conduct of Celebrity Genetics could be regulated. First, a law could be enacted to prohibit possession of a biological specimen with the intent to perform a genetic test without consent. This approach, treating the specimen as contraband, is used in the U.K. Human Tissue Act.227 Second, assuming that obtaining human tissue without consent is made unlawful, a law also could be enacted to prohibit the solicitation of human tissue obtained without consent. This prohibition on soliciting unlawful conduct would likely be upheld despite any First Amendment claims.228 Third, a law could be enacted to prohibit the sale of genetic information revealed by the testing of a biological sample obtained without consent. Finally, a law could be enacted to require that Internet service providers block the sites of purveyors of genetic information, such as Celebrity Genetics. Such a law, however, is unlikely to withstand constitutional scrutiny.229
C. A Preliminary Legislative Agenda
Existing laws are inadequate to address the issue of genetic stalking. Because of the potentially national scope of the genetic stalking enterprise and the desirability of uniformity, congressional action should be undertaken to address the issue. The following recommendations are based on the assumption that a possible statute would be directed specifically and exclusively to unauthorized seizure, testing, and disclosing of genetic information. Such an approach, often referred to as “genetic exceptionalism,”230 has been criticized by commentators231 but embraced by legislators.232
In my view, genetic tests and genetic information generally should not be treated differently from other medical tests and information in the absence of a compelling reason.233 Conceptually, it would be better to regulate any individual or entity performing any biological testing of human specimens. Nevertheless, it might be extraordinarily difficult to craft broad legislation that would ban any ill-advised, poorly performed, and nonconsensual medical testing without having unintended consequences such as prohibiting harmless biological analyses.234 Furthermore, at the present time, the principal risk of testing biological specimens left on discarded objects is that the sample will be subjected to genetic testing. It is possible that the development of new, non-genetic analytical techniques would require amendment of the statute.
The following eight elements should be included in genetic stalking legislation.
1. Comprehensive Regulation of Laboratories
All laboratories performing genetic testing of human specimens should be subject to federal regulation, and only tests certified as meeting acceptable scientific standards of analytical validity, clinical validity, and clinical utility should be approved.
2. Regulatory REORGANIZATION
A new or reorganized regulatory authority should be created within the Department of Health and Human Services to oversee the approval of all new genetic tests for clinical, forensic, or commercial use, as well as to ensure compliance with good laboratory practices. The professional organizations currently involved in the regulatory process should continue to have a defined advisory role in the new regulatory system.235
3. Consent
Verified,236 express,237 written consent of the individual whose biological specimen is tested should be required for all genetic testing not ordered by a health care professional with statutory authority to order a genetic test. This requirement would apply to both “walk-in” and home-collection testing. Genetic testing in health care settings would continue to be governed by established standards of medical practice, state medical practice acts, and professional accreditation standards. Written consent should not be required for all genetic testing in health care settings.238
4. Testing Minor Children
Any genetic testing of minor children to determine their parentage should be unlawful without the verified, express written consent of both legal parents, except pursuant to a court order. Much of the current, Internet-based genetic testing without consent involves men with child-support obligations who are suspicious of the paternity of their children. Curiosity parentage testing by noncustodial fathers has the potential to disrupt families and should be restricted.239 Genetic testing of minor children for health care purposes should be regulated by state laws dealing with parental authority to consent for the health care of minors.
5. Specimens
Subject to narrowly defined exceptions for law enforcement, national security, public health, and other specific purposes, no genetic testing should be permitted using a specimen other than a blood sample, a buccal swab, or another specimen collected using generally accepted laboratory practices, except where the testing is pursuant to a court order. The effect of this provision would be to prohibit the testing of chewing gum, cigarette butts, and other abandoned or pilfered items obtained without consent. If testing is performed with consent, then only standard laboratory collection methods would be used.
6. Solicitations
Advertising or soliciting to perform any genetic testing service in violation of these requirements (e.g., testing abandoned objects, testing without consent) using any medium (including the Internet) or misrepresenting that any laboratory or genetic test has received the appropriate regulatory approval should be unlawful.240 Although aggressive enforcement of this provision is essential, it remains to be seen whether federal or state regulators would have the resources or political support to undertake such action.
7. Sale of Information
Selling individually-identifiable genetic information without the verified, express, written consent of the individual should be unlawful,241 except that the sale of an object containing or possibly containing genetic material should be permissible so long as the sale is not for the purpose of analyzing the genetic material without such consent of that individual. For example, the sale of a letter and envelope from a famous person should not be unlawful merely because there may be DNA on the envelope or stamp.242
8. Sanctions
A range of civil and criminal sanctions for violations should be provided, there should be stringent enforcement of the regulatory provisions, and individuals harmed by unlawful conduct in violation of the statute should have a private right of action for damages and other appropriate relief.
VI. Conclusion
In the futuristic film Gattaca, the female lead, played by Uma Thurman, Surreptitiously obtains a hair of her romantic interest, the film’s protagonist, played by Ethan Hawke.243 She takes the hair to a laboratory that appears to specialize in the stealth genetic assessment of prospective mates.244 For a seemingly nominal fee, and in a matter of seconds, the laboratory presents her with the results of a full genome sequence analysis and an overall assessment of “9.3,” which, she is told, makes the sample source “quite a catch.”245 This aspect of the futuristic world portrayed in Gattaca is not science fiction; it is here today. The only differences are that today’s genetic testing is not available “while you wait,”246 only genome-wide association analyses rather than full sequence data are commercially available today,247 and the genetic testing of the future presumably would be more accurate than what is commercially touted today.248
Genetic stalking and voyeurism involving celebrities serve to draw attention to the issue, but the underlying privacy concerns of surreptitious genetic testing are anything but frivolous and have population-wide applicability. Genetic information is among the most sensitive health and personal information about an individual.249 Without legislation prohibiting nonconsensual DNA analysis, human dignity and public civility will be irretrievably lost. Society will have succeeded in reaching a level of “zero” privacy and it will not be easy or desirable to “get over it.”
The recommendations for legislation in this Article address only one part of the wider problem of the lack of privacy protections for health information, including the commercial exploitation of health information. For example, the United States does not have a comprehensive health privacy law;250 the closest thing to such a law is the HIPAA Privacy Rule, which has limited coverage,251 weak protections,252 and virtually no enforcement.253 The newly enacted federal genetic nondiscrimination law, GINA, does not address the use of genetic information in life insurance, disability insurance, long-term care insurance, mortgages, or numerous other contexts.254 The proposals in this Article are directed primarily at commercial uses of genetic Information; they do not address the exploitation of genetic information that is not a direct sale, such as by posting genetic information on a commercial site supported by advertising revenues. These and numerous other issues are beyond the scope of this Article.
Today, in the health care setting, a genetic test intended to benefit the patient may be ordered only by a licensed physician with informed consent from the patient,255 the testing must be performed by a certified clinical laboratory,256 and the confidentiality of the results must be maintained in accordance with the HIPAA Privacy Rule.257 Should strangers be permitted to acquire an individual’s DNA sample on an inanimate object surreptitiously without any consent, arrange for an unregulated laboratory to perform genetic testing on the sample, and widely publish the results when the motivation is curiosity, commercial exploitation, or some other trivial, voyeuristic, or nefarious purpose?
Acknowledgments
Research on this Article was supported, in part, by the Kentucky Research Challenge Trust Fund. Kristen Kohn, University of Maryland School of Law Class of 2010, provided excellent research assistance. Additional administrative and research assistance was provided by Robert Klein. The author is indebted to Lori Andrews, Leslie Francis, and Bob Gellman for helpful comments on an earlier draft.
References
- 1.This is a hypothetical website. The author owns the domain name, www.celebritygenetics.com, to prevent its use by others for commercial purposes. Of course, numerous similar domain names are available. Even if no commercial website is ever created, the genetic privacy issues raised by the nonconsensual testing of non-celebrities are important to consider.
- 2.See generally Calvert Clay. Voyeur Nation: Media, Privacy, and Peering in Modern Culture. 2004.
- 3.A detailed discussion of Internet-based DNA testing for health-related purposes is beyond the scope of this Article. It should be noted, however, that several other forms of Internet-based DNA testing for health purposes have generated considerable controversy. Examples of DNA testing for health purposes include genome-wide association studies, see generally McCarthy Mark I, et al. Genome-Wide Association Studies for Complex Traits: Consensus, Uncertainty and Challenges. 9 Nature Revs Genetics. 2008;356 doi: 10.1038/nrg2344.; pharmacogenomics, see generally Katsanis SH, Javitt G, Hudson K. A Case Study of Personalized Medicine. 320 Science. 2008;53 doi: 10.1126/science.1156604.; and nutrigenomics, see generally Goddard Katrina AB, et al. Awareness and Use of Direct-to-Consumer Nutrigenomic Tests, United States, 2006. 9 Genetics in Med. 2007;510 doi: 10.1097/gim.0b013e31812e6ac3.
- 4.See Rothstein Mark A, Talbott Meghan K. The Expanding Use of DNA in Law Enforcement: What Role for Privacy? 34 JL Med & Ethics. 2006;153:155–56. doi: 10.1111/j.1748-720X.2006.00024.x. (describing the use of DNA dragnets). See generally Joseph Wambaugh, The Blooding (1989) (describing the first forensic use of a DNA technique developed by Alec Jeffreys to identify a serial rapist in England). The seizure and analysis of abandoned objects by law enforcement officials to prevent and solve crimes is generally lawful, see infra notes 25–39 and accompanying text, but in some circumstances DNA analysis by law enforcement officials may be so extensive or invasive as to raise privacy concerns. Among the more controversial applications of DNA testing in law enforcement are DNA dragnets (testing all individuals—usually all men—in a geographic area), Rothstein & Talbott, supra, at 155–56, indirect testing of suspects by obtaining the DNA of relatives (including their children), id. at 156, low stringency searches where there is an incomplete match, id. at 156–57, and analysis of genetic material stored in health care facilities, id. at 157–58. Thus, regardless of the constitutionality of the law enforcement practices, aggressive and expansive use of DNA testing may not be sound policy.
- 5.E.g., State v. Athan, 158 P.3d 27, 31–32 (Wash. 2007).
- 6.E.g., Hudson v. State, 205 S.W.3d 600, 602 (Tex. Ct. App. 2006).
- 7.E.g., Commonwealth v. Perkins, 883 N.E.2d 230, 237 (Mass. 2008); State v. Reed, 641 S.E.2d 320, 321 (N.C. Ct. App. 2007).
- 8.E.g., People v. LaGuerre, 815 N.Y.S.2d 211, 213 (N.Y. App. Div. 2006).
- 9.See generally Imwinkelreid Edward J, Kaye DH. DNA Typing: Emerging or Neglected Issues. 76 Wash L Rev. 2001;413:436–40. (describing other surreptitious DNA collection methods); Elizabeth E. Joh, Reclaiming “Abandoned” DNA: The Fourth Amendment and Genetic Privacy, 100 Nw. U. L. Rev. 857 (2006) (same); Amy Harmon, Lawyers Fight DNA Samples Gained on Sly, N.Y. Times, Apr. 3, 2008, at A1 (same).
- 10.See Dorothy Nelkin, Paternity Palaver in the Media: Selling Identity Tests, in Genetic Ties and the Family: The Impact of Paternity Testing on Parents and Children 3, 5 (Mark A. Rothstein et al. eds., 2005) (noting paternity tests were advertised on taxicabs in New York City and billboards in Baltimore).
- 11.See id. (stating laboratories receive calls and visits from men seeking to resolve suspicions about the fidelity of their wives).
- 12.Id. at 6. By 2000, laboratories accredited by the American Association of Blood Banks performed over 300,000 DNA-based paternity tests, and the number of tests performed by the numerous unaccredited laboratories is unknown. Am. Ass’n of Blood Banks, Annual Report Summary for Testing in 2004, at 3, 12 (2004), available at http://www.aabb.org/Documents/Accreditation/Parentage_Testing_Accreditation_Program/rtannrpt04.pdf. The results of DNA testing based on home-collection kits are inadmissible in court because, among other things, there is no way to verify the source of the specimens. See Anderlik Mary R. Assessing the Quality of DNA-Based Parentage Testing: Findings from a Survey of Laboratories. 43 Jurimetrics J. 2003;291:295–299. (noting home-test results cannot be used for “any official purpose”). If the “unofficial” test result indicates misattributed paternity, however, a petition can be filed for court-ordered testing. See id. at 308 (noting some people use tests to confirm paternity before entering into court proceedings).
- 13.DNA Home Test or Forensic Acceptable Samples, http://www.dnatestingcentre.com/samples.htm (last visited Nov. 6, 2008).
- 14.Surreptitious testing for the presence of semen on linens, clothing, and other objects has been touted as a basis for “infidelity” testing. See Semen and Sperm Detection, Inc., http://www.semen-detection.com (last visited Nov. 6, 2008).
- 15.According to published reports, when the President of the United States travels abroad, he uses a special toilet, which is then flown back to Washington to be emptied. The goal is to prevent foreign countries from performing genetic testing or other analyses of his fecal matter, something allegedly done in the past on foreign rulers. Paul Krassner, Excrement in the News, The Huffington Post, July 6, 2006, http://www.huffingtonpost.com/paul-krassner/excrement-in-the-news_b_24536.html (describing the security measures taken to protect the President’s medical conditions). As a practical matter, it would seem an impossible task to prevent anyone’s DNA from being obtained. The President would need to have his own glassware, utensils, and other objects, and practically live in a bubble, which would not be conducive to diplomacy.
- 16.New automated DNA testing methods make it feasible to test simultaneously for hundreds of thousands of single nucleotide polymorphisms which, to varying degrees, may be associated with an increased likelihood of various health and behavioral outcomes. See McCarthy et al., supra note 3, at 367 (“Genome wide association (GWA) studies are proving adept at identifying common variants contributing to the inherited component of common diseases.”).
- 17.When Britney Spears had her hair shaved at Esther Tognozzi’s salon in Los Angeles, her hair and the clippers used to cut it were reportedly offered for sale on e-Bay. Lisa Ingrassia, After the Shave: Britney Goes Clubbing, People, Feb. 20, 2007, http://www.people.com/people/article/0,,20012318,00.html; International Biosciences, DNA Testing—The Secrets of Celebrity, http://www.ibdna.com/regions/UK/EN/?page=secretsOfCelebrity (last visited July 18, 2008).
- 18.See, e.g., Makdisi June Mary Z. Genetic Privacy: New Intrusion a New Tort? 34 Creighton L Rev. 2001;965:971–72. (“[E]xcluding others from probing one’s unique genetic make-up is vital to maintaining dignity through privacy.”).
- 19.Other forms of nonconsensual genetic testing, or “genetic stalking,” are taking place. For example, some individuals doing genealogical research who are unsuccessful in obtaining biological specimens with the consent of relatives, stalk the relatives to collect and test samples from discarded objects. In one reported incident, an individual took hairs from her deceased grandmother in her casket. Matejik Laura A. DNA Sampling: Privacy and Police Investigation in a Suspect Society. 61 Ark L Rev. 2008;53:81. (citing Amy Harmon, Stalking Strangers’ DNA to Fill in the Family Tree, Deseret Morning News, Apr. 2, 2007, at A01).
- 20.Erwin Chemerinsky, Constitutional Law: Principles and Policies § 10.1.1, at 792 (3d ed. 2006).
- 21.See id. § 11.3.5.5, at 1060–61 (explaining the Supreme Court’s analysis of liability for invasion of privacy when information is obtained by a nongovernment source and the likelihood the Court will revisit this issue).
- 22.The Fourth Amendment provides:The right of the people to be secure in their persons, houses, papers, and effects, against unreasonable searches and seizures, shall not be violated, and no Warrants shall issue, but upon probable cause, supported by Oath or affirmation, and particularly describing the place to be searched, and the persons or things to be seized.U.S. Const. amend. IV.
- 23.The Supreme Court has interpreted the Fourth Amendment’s protection against unreasonable searches and seizures as being applicable to the states through the Fourteenth Amendment’s Due Process Clause. Mapp v. Ohio, 367 U.S. 643, 655 (1961); see also Chemerinsky, supra note 20, § 6.3.3.
- 24.See infra notes 40–46 and accompanying text.
- 25.California v. Greenwood, 486 U.S. 35, 37 (1988).
- 26.Id. at 45 (Brennan, J., dissenting).
- 27.Id.
- 28.Id. at 38 (majority opinion).
- 29.Id.
- 30.Id. at 39.
- 31.Id. at 40–41.
- 32.Id. at 40 (footnotes omitted).
- 33.Id. at 40 n.4.
- 34.Id. at 45–46 (Brennan, J., dissenting).
- 35.Id. at 54.
- 36.See 1 Wayne R. LaFave, Search and Seizure: A Treatise on the Fourth Amendment § 2.6(b) (3d ed. 1996).
- 37.Abel v. United States, 362 U.S. 217, 224–25 (1960).
- 38.Id. at 220, 225.
- 39.Id. at 241.
- 40.834 A.2d 316 (N.H. 2003).
- 41.Id. at 317.
- 42.Id.
- 43.Id.
- 44.Id.
- 45.Id. at 319.
- 46.See, e.g., State v. Tanaka, 701 P.2d 1274, 1276–77 (Haw. 1985); State v. Hempele, 576 A.2d 793, 800–02 (N.J. 1990); State v. Granville, 142 P.3d 933, 938–41 (N.M. Ct. App. 2006); State v. Morris, 680 A.2d 90, 94 (Vt. 1996); State v. Boland, 800 P.2d 1112, 1116 (Wash. 1990). Contra People v. Hillman, 834 P.2d 1271, 1276 (Colo. 1992); Commonwealth v. Pratt, 555 N.E.2d 559, 567–68 (Mass. 1990); State v. Carriere, 545 N.W.2d 773, 776 (N.D. 1996). For a listing of the state decisions on the issue, see Winbush Kimberly J. Annotation, Searches and Seizures: Reasonable Expectation of Privacy in Contents of Garbage or Trash Receptacle. 62 ALR5th. 1998;1:11–17..
- 47.United States v. Morrison, 529 U.S. 598, 621 (2000); Civil Rights Cases, 109 U.S. 3, 11 (1883) (“Individual invasion of individual rights is not the subject-matter of the [Fourteenth A]mendment.”); see also Chemerinsky, supra note 20, § 6.4.1 (“The Constitution’s protections of individual liberties and its requirement for equal protection apply only to the government. Private conduct generally does not have to comply with the Constitution.”).
- 48.Ariz. Const. art. II, § 8; Cal. Const. art. I, § 1; Haw. Const. art. I, § 6; Ill. Const. art. I, § 6; La. Const. art. I, § 5; Wash. Const. art. I, § 7.
- 49.See, e.g., Loder v. City of Glendale, 927 P.2d 1200, 1230 (Cal. 1997) (discussing Hill v. National Collegiate Athletic Ass’n, 865 P.2d 633 (Cal. 1994), which held that drug testing by private employers is subject to the state constitution’s privacy provision).
- 50.Washington is the only state that appears to clearly reject Greenwood and also to extend constitutional privacy protection beyond governmental actors, but there is no case law in Washington on whether this would extend to abandoned property.
- 51.Lewis J. Paper, Brandeis 33 (1983).
- 52.Id. at 33–35. A recent article documents that between 1882, the date of his “society” engagement to Mabel Bayard, daughter of U.S. Senator Thomas F. Bayard, and the 1890 publication of The Right to Privacy, there were approximately sixty newspaper stories from Boston, New York, and Washington, D.C., reporting on the personal life of Warren and his family. Amy Gajda, What if Samuel D. Warren Hadn’t Married a Senator’s Daughter?: Uncovering the Press Coverage that Led to “The Right to Privacy,” 2008 Mich. St. L. Rev. 35, 44.
- 53.4 Harv. L. Rev. 193 (1890).
- 54.Id. at 205.
- 55.Id. at 195 (quoting Thomas M. Cooley, Cooley on Torts 29 (2d ed. 1888)).
- 56.Id. at 215.
- 57.Id. at 215–16.
- 58.Id. at 220.
- 59.Brandeis, who was appointed to the Supreme Court by President Woodrow Wilson in 1916, also became famous for his defense of the right to privacy against governmental intrusion. See generally Erwin Chemerinsky, Rediscovering Brandeis’s Right to Privacy, 45 Brandeis L.J. 643 (2006–07). A hallmark of his privacy jurisprudence is his majestic dissent in Olmstead v. United States, 277 U.S. 438, 471–85 (1928) (Brandeis, J., dissenting), overruled by Katz v. United States, 389 U.S. 347 (1967), and Berger v. New York, 388 U.S. 41 (1967). Chemerinsky, supra, at 645.
- 60.See W. Page Keeton et al., Prosser and Keeton on Torts 851 (5th ed. 1984).
- 61.William L. Prosser, Privacy, 48 Cal. L. Rev. 383, 389 (1960).
- 62.See, e.g., Bloustein Edward J. Privacy as an Aspect of Human Dignity: An Answer to Dean Prosser. 39 NYU L Rev. 1964;962:1002–03. (“[T]he loss suffered is not one which may be made good by an award of damages. The injury is to our individuality, to our dignity as individuals ….”); see also Richards Neil M, Solove Daniel J. Privacy’s Other Path: Recovering the Law of Confidentiality. 96 Geo LJ. 2007;123:151–52. 156–58. (arguing that the breach of confidence action was a significant omission from Prosser’s categories).
- 63.Restatement (Second) of Torts §§ 652A–652E (1977). Prosser and John W. Wade were the reporters for the Restatement (Second) of Torts.
- 64.Dan B. Dobbs, The Law of Torts 1197–98 (2000); see Keeton et al., supra note 60, at 849–51.
- 65.Restatement (Second) of Torts § 652B (1977).
- 66.Keeton et al., supra note 60, at 854–55.
- 67.Restatement (Second) of Torts § 652B (1977).
- 68.See, e.g., Kobeck v. Nabisco, Inc., 305 S.E.2d 183, 185 (Ga. Ct. App. 1983) (holding that the mere disclosure of attendance records by employer to the husband of an employee was not an intrusion of privacy).
- 69.Dobbs, supra note 64, at 1201.
- 70.Keeton et al., supra note 60, at 856.
- 71.A leading article on intrusion in the context of genetics is Makdisi, supra note 18.
- 72.Even if this aspect of the tort were attributable to the laboratory, it could be asserted that both the party acquiring the sample and the party analyzing the sample were joint tortfeasors.
- 73.Makdisi, supra note 18, at 992.
- 74.See, e.g., I.C.U. Investigations, Inc. v. Jones, 780 So. 2d 685, 689–90 (Ala. 2000) (finding no liability where investigators on public property videotaped an employee suspected of engaging in workers’ compensation fraud).
- 75.E.g., Daily Times Democrat v. Graham, 162 So. 2d 474, 478 (Ala. 1964).
- 76.E.g., Nader v. Gen. Motors Corp., 255 N.E.2d 765, 770–71 (N.Y. 1970).
- 77.E.g., Wolfson v. Lewis, 924 F. Supp. 1413, 1420, 1432–34 (E.D. Pa. 1996).
- 78.Doe v. Dyer-Goode, 566 A.2d 889, 891 (Pa. Super. Ct. 1989).
- 79.Id.
- 80.Doe v. High-Tech Inst., Inc., 972 P.2d 1060, 1067 (Colo. Ct. App. 1998); see also Blackwell v. Harris Chem. N. Am., Inc., 11 F. Supp. 2d 1302, 1310 (D. Kan. 1998) (holding employer’s harassment and badgering of employee’s physician’s office to disclose confidential information created a claim for intrusion).
- 81.High-Tech Inst., Inc., 972 P.2d at 1065, 1069.
- 82.See Dobbs, supra note 64, at 1208.
- 83.Restatement (Second) of Torts § 652D (1977).
- 84.E.g., Miller v. Motorola, Inc., 560 N.E.2d 900, 902–03 (Ill. App. Ct. 1990).
- 85.E.g., Trought v. Richardson, 338 S.E.2d 617, 619 (N.C. Ct. App. 1986); Eddy v. Brown, 715 P.2d 74, 78 (Okla. 1986); Wells v. Thomas, 569 F. Supp. 426, 437 (E.D. Pa. 1983); Shattuck-Owen v. Snowbird Corp., 16 P.3d 555, 559 (Utah 2000); see Lemnah v. Am. Breeders Servs., Inc., 482 A.2d 700, 704–05 (Vt. 1984) (holding that disclosure to customers was insufficient when there was not evidence that the disclosure was disseminated to public at large); see also Doe v. Se. Pa. Transp. Auth., 72 F.3d 1133, 1143 (3d Cir. 1995) (holding that disclosure to management employees was a “minimal intrusion” of plaintiff’s constitutional right to privacy).
- 86.See, e.g., Robert C. Ozer, P.C. v. Borquez, 940 P.2d 371, 378 (Colo. 1997) (determination of sufficient disclosure depends on facts and circumstances of each case); Levias v. United Airlines, 500 N.E.2d 370, 375 (Ohio Ct. App. 1985) (upholding a verdict against an employer when its medical examiner released information to plaintiff’s supervisors even though they did not have “a real need to know” the disclosed data).
- 87.See, e.g., Davis v. Monsanto Co., 627 F. Supp. 418, 421–22 (S.D. W. Va. 1986) (finding no violation when the disclosure was made to the employer to protect employees from a dangerous coworker); Young v. Jackson, 572 So. 2d 378, 382–85 (Miss. 1990); Crump v. Beckley Newspapers, Inc., 320 S.E.2d 70, 77–79 (W. Va. 1983).
- 88.Restatement (Second) of Torts § 652D cmt. b (1977).
- 89.See, e.g., Urbaniak v. Newton, 277 Cal. Rptr. 354, 360 (Cal. Ct. App. 1991) (“Under the test of tortious invasion of privacy, [HIV positive status] is clearly a ‘private fact ….’”); Robert C. Ozer, P.C., 940 P.2d at 377 (“[F]acts related to … ‘unpleasant or disgraceful’ illnesses are considered private in nature.”).
- 90.See Paul P. v. Verniero, 170 F.3d 396, 403–04 (3d Cir. 1999) (holding that sex offender’s identity was a public record under state law); cf. Baker v. Burlington N., Inc., 587 P.2d 829, 833 (Idaho 1978) (noting that past criminal conduct may become a private matter after the passage of time).
- 91.See Trout v. Umatilla County Sch. Dist., 712 P.2d 814, 817–18 (Or. Ct. App. 1985) (observing that a crash involving drunk school teachers was widely known before the school district published disciplinary measures).
- 92.113 F.2d 806 (2d Cir. 1940).
- 93.Id. at 807.
- 94.Id.
- 95.See id. at 809 (noting that when intrusions are “focused upon public characters, truthful comments upon dress, speech, habits, and the ordinary aspects of personality will usually not transgress [the] line” of decency).
- 96.By contrast, in cases involving intentional infliction of emotional distress, the courts use an objective standard, unless the defendant knew of the plaintiff’s heightened sensitivity or vulnerability. Keeton et al., supra note 60, at 62–63.
- 97.See Dobbs, supra note 64, at 1204–05 (“[I]f the interviewer had gained entry into Sidis’ room and mind by deceit and breach of confidence, liability of the interviewer would have been entirely appropriate.”).
- 98.Sipple v. Chronicle Publ’g Co., 201 Cal. Rptr. 665, 666 (Cal. Ct. App. 1984).
- 99.Id.
- 100.Id. at 669–70.
- 101.665 F.2d 305 (10th Cir. 1981).
- 102.Id. at 306.
- 103.Id. at 308–09.
- 104.Dobbs, supra note 64, at 1208. For a further discussion of statutory regulation of publishing information and First Amendment concerns, see infra notes 217–23 and accompanying text.
- 105.Restatement (Second) of Torts § 652E (1977). The history of the tort is often traced to 1816, “when Lord Byron succeeded in enjoining the circulation of a bad poem which had been attributed to his pen.” Keeton et al., supra note 60, at 863 (citing Lord Byron v. Johnston, 35 Eng. Rep. 851 (1816)). Improper attribution is still the basis of some false light claims. See, e.g., Jonap v. Silver, 474 A.2d 800, 802 (Conn. App. Ct. 1984) (letter critical of FDA falsely attributed to the plaintiff was published in a trade magazine).
- 106.Keeton et al., supra note 60, at 864.
- 107.Dobbs, supra note 64, at 1208–09.
- 108.Keeton et al., supra note 60, at 867–68.
- 109.385 U.S. 374 (1967).
- 110.See New York Times Co. v. Sullivan, 376 U.S. 254, 279–80 (1964).
- 111.Time, Inc., 385 U.S. at 390.
- 112.Cantrell v. Forest City Publ’g Co., 419 U.S. 245, 254 (1974).
- 113.This could arise where the publisher failed to make a reasonable effort to verify that the biological specimen was that of the celebrity or the testing was performed in a scientific manner. In Bilodeau-Allen v. American Media, Inc., 549 F. Supp. 2d 129, 129–30 (D. Mass. 2008), a mother and son brought a false light invasion of privacy claim against a tabloid for allegedly running a false story that the son was the illegitimate child of a United States senator. Although the action was dismissed because Massachusetts law does not recognize the tort of false light invasion of privacy, id. at 130–31, the facts could be replicated where paternity or non-paternity findings based on genetic test results are published with knowledge of their falsity or a reckless disregard for their truthfulness.
- 114.Restatement (Second) of Torts § 652C (1977).
- 115.See, e.g., Ainsworth v. Century Supply Co., 693 N.E.2d 510 (Ill. App. Ct. 1998); Johnson v. Boeing Airplane Co., 262 P.2d 808 (Kan. 1953); Shepard’s Pharmacy, Inc. v. Stop & Shop Cos., 640 N.E.2d 1112 (Mass. App. Ct. 1994); Staruski v. Cont’l Tel. Co., 581 A.2d 266 (Vt. 1990).
- 116.Restatement (Second) of Torts § 652C cmt. c (1977).
- 117.See generally Jayaprakash Azza. Sum of Your Parts: Are There Adequate Remedies for Victims of Fraudulent Tissue and Organ Acquisition? 9 DePaul J Health Care L. 2006:1235. (discussing remedies available for improper organ acquisition under tort law, property law, and business ethics).
- 118.Moore v. Regents of the Univ. of Cal., 793 P.2d 479, 481 (Cal. 1990).
- 119.Id. at 481. T-lymphocytes are cells produced in the thymus gland and stored in secondary lymphoid glands—such as the spleen—,bone marrow, and lymph nodes. The Merck Manuals Online Medical Library, http://www.merck.com/mmhe/sec16/ch183/ch183c.html (last visited Nov. 5, 2008). “They circulate in the bloodstream and lymphatic system,” where they search and destroy foreign or abnormal cells, such as bacteria and viruses. Id.
- 120.Moore, 793 P.2d at 481–82.
- 121.Id. at 482.
- 122.Id. at 481.
- 123.Id. at 482. For a discussion of his claim based on conversion, see infra notes 132–36 and accompanying text.
- 124.Moore, 793 P.2d at 490.
- 125.The Merck Manuals Online Medical Library, http://www.merck.com/mmhe/sec01/ch002/ch002b.html?qt=DNA&alt=sh#N10FB9 (last visited Nov. 9, 2008).
- 126.See, e.g., Cal. Civ. Code § 3344 (West 1997); N.Y. Civ. Rts. Law § 51 (McKinney 1992); Okla. Stat. Ann. tit. 21, § 839.1 (West 2002); Va. Code Ann. § 8.01-40 (West 1950).
- 127.Mendonsa v. Time Inc., 678 F. Supp. 967, 968 (D.R.I. 1988).
- 128.Id.
- 129.Id. at 972.
- 130.See, e.g., Moore v. Regents of the Univ. of Cal., 793 P.2d 479, 489 (Cal. 1990).
- 131.“Conversion is an intentional exercise of dominion or control over a chattel which so seriously interferes with the right of another to control it that the actor may justly be required to pay the other the full value of the chattel.” Restatement (Second) of Torts § 222A (1977).
- 132.Moore, 793 P.2d at 482.
- 133.Id. at 488–89.
- 134.Id. at 489. The court referred to a California statute providing for prompt disposal of human tissue, which admittedly was meant to address hazardous waste concerns and not compensation for scientific use of the tissue. Id. at 491. The effect of the court’s holding is to create a “no compensation” default rule. Russell Korobkin, “No Compensation” or “Pro Compensation”: Moore v. Regents and Default Rules for Human Tissue Donations, 40 J. Health L. 1, 9–10 (2007).
- 135.Moore, 793 P.2d at 493–94.
- 136.Id. at 494.
- 137.264 F. Supp. 2d 1064 (S.D. Fla. 2003).
- 138.Canavan disease is a neurological genetic disorder “in which the white matter of the brain degenerates into spongy tissue riddled with microscopic, fluid-filled spaces.” National Institute of Neurological Disorders and Stroke, NINDS Canavan Disease Information Page, http://www.ninds.nih.gov/disorders/canavan/canavan.htm (last visited Nov. 24, 2008). Symptoms, “which appear in early infancy and progress rapidly, may include mental retardation, loss of previously acquired motor skills, feeding difficulties,” paralysis, blindness, and hearing loss. Id. Death usually occurs by age four. Id.
- 139.Greenberg, 264 F. Supp. 2d at 1066.
- 140.Id. at 1067.
- 141.Id.
- 142.Id. at 1068.
- 143.Id. at 1076.
- 144.Id. at 1074–75; see also Wash. Univ. v. Catalona, 490 F.3d 667, 675 (8th Cir. 2007), cert. denied, 128 S. Ct. 1122 (2008) (holding that patients who authorized their surgeon and his colleagues to use excised tissue for research did not retain any property interest in their tissue, and therefore, they could not authorize their surgeon to take the tissue with him to his new university).
- 145.Greenberg, 264 F. Supp. 2d at 1066–67; Moore v. Regents of the Univ. of Cal., 793 P.2d 479, 481 (Cal. 1990).
- 146.Greenberg, 264 F. Supp. 2d at 1076; Moore, 793 P.2d at 493–97.
- 147.Greenberg, 264 F. Supp. 2d at 1067; Moore, 793 P.2d at 482.
- 148.The owner of an object taken for analysis (e.g., linen napkin) would have an action for conversion, but the value of the object is unlikely to justify the cost of litigation. The owner of the object, unless it is also the person whose DNA is analyzed, would not have standing to assert the claims based on genetic testing and publication of the results.
- 149.For a compilation of these laws, see National Conference of State Legislatures, State Genetic Privacy Laws, updated June 2008, http://www.ncsl.org/programs/health/genetics/prt.htm (last visited Nov. 9, 2008).
- 150.Id.
- 151.Id.
- 152.Id. The states are Alaska, Arizona, Florida, Georgia, Massachusetts, Michigan, Nebraska, New Mexico, New York, South Carolina, South Dakota, and Vermont.
- 153.Mass. Gen. Laws Ann. ch. 111, § 70G(c) (West 2003); Mich. Comp. Laws Ann. §§ 333.17020, 333.17520 (West 2008); Neb. Rev. Stat. § 71–551 (Supp. 2007).
- 154.Ga. Code Ann. § 33-54-3(b) (West 2003).
- 155.S.D. Codified Laws § 34-14-21 to -22 (2004).
- 156.N.Y. Civ. Rights § 79-1(2)(a) (McKinney Supp. 2008); S.C. Code Ann. § 38-93-40 (2002).
- 157.Alaska Stat. § 18.13.010(a)(1) (2007).
- 158.Vt. Stat. Ann. tit. 18, § 9332(d) (2007).
- 159.Ariz. Rev. Stat. Ann. § 20-448.02 (2002); Fla. Stat. Ann. § 760.40 (West Supp. 2009); N.M. Stat. § 24-21-3 (2003).
- 160.A debate on the same issue, whether it was possible to protect privacy in the face of new developments in the media, took place at the beginning of the twentieth century with the advent of cheaper printing and photographic technology. Daniel J. Solove, The Future of Reputation: Gossip, Rumor, and Privacy on the Internet 110 (2007).
- 161.Olmstead v. United States, 277 U.S. 438, 471–85 (1928) (Brandeis, J., dissenting), overruled by Katz v. United States, 389 U.S. 347 (1967), and Berger v. New York, 388 U.S. 41 (1967). The Supreme Court eventually adopted Brandeis’s view in Katz v. United States, 389 U.S. 347 (1967).
- 162.Olmstead, 277 U.S. at 472–73 (Brandeis, J., dissenting) (quoting Weems v. United States, 217 U.S. 349, 373 (1910)).
- 163.Id. at 472 (“[I]ndividual protections against specific abuses of power, must have a … capacity of adaption to a changing world.”).
- 164.Polly Sprenger, Sun on Privacy: ‘Get Over It,’ Wired, Jan. 26, 1999, http://www.wired.com/politics/law/news/1999/01/17538. Mr. McNealy recently repeated this statement and reaffirmed his support for the underlying principle at a conference where he and the author spoke, the World Congress on Health Information Technology, Washington, D.C., Dec. 10, 2008.
- 165.Genetic Information Nondiscrimination Act, Pub. L. No. 110–233, 122 Stat. 881 [hereinafter GINA] (codified in scattered sections of U.S.C. titles 26, 29, and 42).
- 166.See Slaughter Louise M. Your Genes and Privacy. 316 Science. 2007;797:797. doi: 10.1126/science.1144588. (discussing legislative history of federal genetic nondiscrimination legislation).
- 167.GINA §§ 101(a), 102, 201(4), 202.
- 168.Id. §§ 101, 102, 202.
- 169.E.g., Mark A. Hall & Stephen S. Rich, Genetic Privacy Laws and Patients’ Fear of Discrimination by Health Insurers: The View from Genetic Counselors, 28 J.L. Med. & Ethics 245, 245 (2000).
- 170.See Slaughter, supra note 166.
- 171.GINA § 2.
- 172.Id. § 2(5).
- 173.See, e.g., Mark A. Rothstein, Putting the Genetic Information Nondiscrimination Act in Context, 10 Genetics in Med. 655, 655–56 (2008); Mark A. Rothstein, Is GINA Worth the Wait?, 36 J.L. Med. & Ethics 174, 174 (2008).
- 174.Rothstein, Putting the Genetic Information Nondiscrimination Act in Context, supra note 173, at 655.
- 175.GINA §§ 101(a)(3)(B) (group health insurance), 102(b)(1)(B) (individual health insurance), 210 (employment).
- 176.GINA § 102(b)(1)(B). To prevent such adverse treatment, the concept of medical underwriting would need to be removed from individual health insurance policies. This would not occur in the absence of a major overhaul of the health finance system of the United States. For this reason, so-called genetic discrimination in health insurance is less about genetics than it is about the issue of who has access to health care and under what mechanism. See Korobkin Russell, Rajkumar Rahul. The Genetic Information Nondiscrimination Act—A Half-Step Toward Risk Sharing. 359 New Eng J Med. 2008:335–37. doi: 10.1056/NEJMp0804352.); Rothstein Mark A. Genetic Exceptionalism and Legislative Pragmatism. 35 Hastings Ctr Rep. 2005;(4):27..
- 177.GINA § 102(b).
- 178.Mark A. Rothstein, GINA, the ADA, and Genetic Discrimination in Employment, 36 J.L. Med. & Ethics 425, 427 (2008).
- 179.For a more positive view of GINA, see Hudson Kathy L, Holohan MK, Collins Francis S. Keeping Pace with the Times—The Genetic Information Nondiscrimination Act of 2008. 358 New Eng J Med. 2008:2661. doi: 10.1056/NEJMp0803964..
- 180.Numerous state laws also prohibit genetic discrimination in health insurance and employment. At least forty-four jurisdictions prohibit genetic discrimination in individual health insurance. See National Conference of State Legislatures, Genetic Information: Legal Issues Relating to Discrimination and Privacy, http://www.ncsl.org/programs/health/genetics/ndishlth.htm (last visited Nov. 9, 2008). At least thirty-five jurisdictions prohibit genetic discrimination in employment. See National Conference of State Legislatures, State Genetic Employment Laws, http://www.ncsl.org/programs/health/genetics/ndiscrim.htm (last visited Nov. 9, 2008). Employer-sponsored group health plans are regulated by federal law, and a provision of the Health Insurance Portability and Accountability Act prohibits genetic discrimination by such plans. 42 U.S.C. § 300gg-1(a)(1)(F) (2000).
- 181.Pub. L. 108–495, 118 Stat. 4001 (codified at 18 U.S.C. § 1801 (2006)).
- 182.18 U.S.C. §§ 1801(a), 3571(b)(5) (2006).
- 183.H.R. Rep. No. 108–504, at 2 (2004), as reprinted in 2004 U.S.C.C.A.N. 3292, 3293.
- 184.See id. at 2–3.
- 185.Id. at 3.
- 186.Id. Forty-seven states have enacted laws prohibiting video voyeurism, but they vary in definitions and punishment. See The National Center for Victims of Crime, Video Voyeurism Laws, http://www.ncvc.org/src/AGP.Net/Components/DocumentViewer/Download.aspxnz?DocumentID=40459 (last visited Nov. 6, 2008).
- 187.Human Tissue Act 2004, c. 30 (Eng.).
- 188.Human Tissue Act 2004, Explanatory Note, ¶ 5.
- 189.See Human Tissue Act 2004, §§ 13–15.
- 190.Id. § 45(3).
- 191.Section 45 of the Act, entitled “Non-consensual analysis of DNA,” provides in pertinent part:A person commits an offence if —(a) he has any bodily material intending —(i) that any human DNA in the material to be analysed without qualifying consent, and(ii) that the results of the analysis be used otherwise than for an excepted purpose …. Id. § 45(1).
- 192.Human Tissue Act 2004, Explanatory Note, ¶ 58.
- 193.Prince Harry “Honey Trap” Allegations, BBC News World Edition, Dec. 15, 2002, http://news.bbc.co.uk/1/hi/uk/2577539.stm.
- 194.Id.
- 195.Colin Brown, Secret Testing on “Stolen” DNA to Be Outlawed, Telegraph.co.uk, June 15, 2003, available at http://www.telegraph.co.uk/news/uknews/1433037/Secret-testing-on-stolen-DNA-to-be-outlawed.html.
- 196.Chris Williams, Internet DNA Test Kits Could Land You Three Years, The Register, Sept. 1, 2006, http://www.theregister.co.uk/2006/09/01/dna_sampling_ban/print.html.
- 197.E-mail from Stuart Giblin, Communications Officer of the Human Tissue Authority, to Natasha Loder, Science & Technology Correspondent, The Economist (June 16, 2008) (on file with author). A single prosecution has been brought under Section 32 against a man who was advertising to sell one of his kidneys. Id.
- 198.In general, stalking is a course of conduct “in which one individual inflicts on another repeated unwanted intrusions and communications,” to such an extent that the victim fears for his or her safety. Pathé Michele, Mullen Paul E. The Impact of Stalkers on Their Victims. 170 Brit J Psychiatry. 1997;12:12. doi: 10.1192/bjp.170.1.12.. Various criminal laws prohibiting stalking include their own definitions. Related crimes include menacing and harassment. For a complete list of state and federal stalking laws, see National Center for Victims of Crime, Stalking Resource Center, http://www.ncvc.org/src/main.aspx?dbID=DB_Register204 (last visited June 18, 2008).
- 199.See, e.g., Galella v. Onassis, 487 F.2d 986, 998–99 (2d Cir. 1973) (affirming and modifying an injunction prohibiting a freelance photographer from, among other things, coming within twenty-five feet of Jacqueline Kennedy Onassis or her children or engaging in any conduct that would be reasonably foreseeable to cause harassment, alarm, or fright); Nader v. Gen. Motors Corp., 255 N.E.2d 765, 770–71 (N.Y. 1970) (wiretapping, but not surveillance or questioning the friends of a consumer advocate, constituted an invasion of privacy under District of Columbia law).
- 200.See, e.g., Anemona Hartocollis, The Pursuer of Thurman is Convicted, N.Y. Times, May 7, 2008, at B1.
- 201.See, e.g., Jessica Simpson’s Gum Selling on Ebay, http://www.simplydumb.com/?p=278&akst_action=share-this (last visited Nov. 10, 2008).
- 202.See supra notes 187–92 and accompanying text.
- 203.College of American Pathologists, CAP Facts, http://www.cap.org (last visited Nov. 10, 2008).
- 204.42 U.S.C. § 263a (2000).
- 205.Pub. L. No. 100–578, 102 Stat. 2903.
- 206.Dep’t of Health & Human Servs., Secretary’s Advisory Committee on Genetics, Health & Society, U.S. System of Oversight of Genetic Testing: A Response to the Charge of the Secretary of Health and Human Services 100 (2008) [hereinafter Dep’t of Health & Human Servs. Report].
- 207.American Society of Crime Laboratory Directors/Laboratory Accreditation Board, http://www.ascld-lab.org/dual/aslabdualobjectives.html (last visited Feb. 8, 2009); NFSTC, http://www.nfstc.org/aboutus/index.htm (last visited Feb. 8, 2009).
- 208.American Association of Blood Banks, Relationship Testing Accreditation Program, http://www.aabb.org/Content/Accreditation/Parentage_Testing_Accreditation_Program/ (last visited Nov. 5, 2008). Because earlier parentage testing used serology rather than genetic analysis, the accreditation responsibility initially was given to the American Association of Blood Banks, where it has remained. A New Generation of Genomics: The Impact of Molecular Testing Methods on Blood Bank Operations and Clinical Care, AABB News, http://www.aabb.org/Content/News_and_Media/Latest_News/news0811a.htm (last visited Feb. 7, 2009).
- 209.Dep’t of Health & Human Servs. Report, supra note 206, at 96.
- 210.Andrew Pollack, Gene Testing Questioned by Regulators, N.Y. Times, June 26, 2008, at C1. Responding to consumer complaints, California and New York have sent letters to 23andMe, deCODE genetics, Navigenics, and other Internet-based companies to inform them that performing genetic testing without a physician’s approval violates state law. David Ewing Duncan, Block That Test!, Condé Nast Portfolio.com, Apr. 21, 2008, http://www.portfolio.com/news-markets/top-5/2008/04/21/Legal-Challenge-to-Retail-DNA-Tests.
- 211.45 C.F.R. §§ 160.102, 164.104 (2007).
- 212.The most common basis for inadmissibility is the lack of evidence of a chain of custody. See generally Anderlik, supra note 12, at 299–303.
- 213.See generally Sarah E. Gollust, Benjamin S. Wilfond & Sara Chandros Hull, Direct-to-Consumer Sales of Genetic Services on the Internet, 5 Genetics in Med. 332 (2003) (describing survey of 105 websites).
- 214.“For DNA-based tests, analytical validity requires establishing the probability that a test will be positive when a particular sequence (analyte) is present (analytical sensitivity) and the probability that the test will be negative when the sequence is absent (analytical specificity).” Final Report of the Task Force on Genetic Testing, Promoting Safe and Effective Genetic Testing in the United States ch. 2 (1997), available at http://www.genome.gov/10002404.
- 215.As stated by the Task Force:Clinical validation involves establishing several measures of clinical performance including (1) the probability that the test will be positive in people with the disease (clinical sensitivity), (2) the probability that the test will be negative in people without the disease (clinical specificity), and (3) the probability that people with positive results will get the disease (positive predictive value (PPV)) and that people with negative results will not get the disease (negative predictive value).Id.
- 216.Clinical utility is “the balance between the benefits and harms of testing and the ensuing follow-up evaluation, treatment, or prevention.” Dep’t of Health & Human Servs. Report, supra note 206, at 117.
- 217.See supra notes 51–129 and accompanying text.
- 218.45 C.F.R. § 160.103 (2007).
- 219.Id. § 164.502.
- 220.See Letter from Simon P. Cohn, Chairman, National Committee on Vital and Health Statistics, to Michael O. Leavitt, Secretary, U.S. Department of Health and Human Services (June 22, 2006) and accompanying report, Privacy and Confidentiality in the Nationwide Health Information Network, http://www.nevhs.hhs.gov/060622lt.htm (last visited Nov. 6, 2008) (advocating such measure).
- 221.See generally Brown Teneille R. Double Helix, Double Standards: Private Matters and Public People. 11 J Health Care L & Pol’y. 2008;295 (raising issue of whether there should be Mandatory genetic testing of political candidates and publication of the results).
- 222.See Ass’n of Am. Physicians & Surgeons, Inc. v. U.S. Dep’t of Health & Human Servs., 224 F. Supp. 2d 1115, 1126 (S.D. Tex. 2002) (HIPAA is a valid exercise of Congress’s power under the Commerce Clause). See generally Developments in the Law—The Law of Media, 120 Harv. L. Rev. 990, 1055–66 (2007) (analyzing media access to health information).
- 223.See Bartnicki v. Vopper, 532 U.S. 514, 535 (2001) (holding that the First Amendment protects publishers from civil liability for publishing information obtained illegally from nongovernmental sources as long as the publisher did not participate in the illegal activity and the matter is of public concern); Cox Broad. Corp. v. Cohn, 420 U.S. 469, 491 (1975) (holding that the First Amendment protects publishers from civil liability for disclosure of private facts when the information is lawfully obtained and truthfully reported); see also Chemerinsky, supra note 20, § 11.3.5.5 (discussing the tort of public disclosure of private facts).
- 224.See generally Mann Ronald J, Belzley Seth R. The Promise of Internet Intermediary Liability. 47 Wm & Mary L Rev. 2005;239:253. (discussing the regulation of Internet-related activity and liability of intermediaries).
- 225.See supra notes 65–129 and accompanying text.
- 226.See supra notes 152–59 and accompanying text.
- 227.Human Tissue Act 2004, c. 30 (Eng.). See supra notes 187–97 and accompanying text.
- 228.In Pittsburgh Press Co. v. Pittsburgh Commission on Human Relations, the Supreme Court held that the newspaper’s First Amendment rights were not infringed by a finding that its gender-segregated want ad column violated the “aiding and abetting” provision of the city’s fair employment ordinance. 413 U.S. 376, 391 (1973). In Central Hudson Gas & Electric Corp. v. Public Service Commission, the Court held that commercial speech concerning an unlawful activity may be regulated. 447 U.S. 557, 563–66 (1980).
- 229.See Ctr. for Democracy & Tech. v. Pappert, 337 F. Supp. 2d 606, 665 (E.D. Pa. 2004) (holding that the blocking provision of Pennsylvania’s Internet Child Pornography Act violated the First Amendment).
- 230.See Thomas H. Murray, Genetic Exceptionalism and “Future Diaries”: Is Genetic Information Different from OTHER Medical Information?, in Genetic Secrets: Protecting Privacy and Confidentiality in the Genetic Era (Mark A. Rothstein ed., 1997) (“[T]he term genetic exceptionalism [means] roughly the claim that genetic information is sufficiently different from other kinds of health-related information that it deserves special protection or other exceptional measures.”).
- 231.See, e.g., Evans James P, Burke Wylie. Genetic Exceptionalism. Too Much of a Good Thing? 10 Genetics in Med. 2008;500:500. doi: 10.1097/gim.0b013e31817f280a. (“[A]s genetic information increasingly becomes medically useful, it challenges the concept of genetic exceptionalism.”); Hellman Deborah. What Makes Genetic Discrimination Exceptional? 29 Am JL & Med. 2003;77:78. (“Critics [of the laws prohibiting genetic discrimination] view them as unjustified and unwarranted.”); Suter Sonia M. The Allure and Peril of Genetics Exceptionalism: Do We Need Special Genetics Legislation? 79 Wash UL Q. 2001;669 (“[G]enetics legislation creates inequalities that legislatures should find morally disturbing.”).
- 232.See supra notes 152, 165–80 and accompanying text.
- 233.See, e.g., Rothstein, Genetic Exceptionalism and Legislative Pragmatism, supra note 176, at 27–28 (“If genetic-specific laws are to be successful, three conditions must be met: (1) the term ‘genetic’ must be defined clearly, logically, and with scientific precision; (2) there must be an efficient, low-cost way to separate genetic information from nongenetic information in health records; and (3) it must not only be possible to treat genetic information differently from other health information, but there must be a compelling reason to do so.”).
- 234.For example, a beauty salon somehow analyzing the hair of a customer before deciding which shampoo to use should not be subject to regulations designed for clinical laboratories.
- 235.See supra notes 203–09 and accompanying text.
- 236.Verification is the process of demonstrating that the individual seeking the testing is, in fact, the person he or she claims to be. It includes presenting picture identification or legal authorization for testing.
- 237.Express consent involves specifically agreeing to have a particular genetic test and understanding the nature and significance of the results.
- 238.With the expected increase of genetic testing in clinical settings, including pharmacogenomic analyses for drug prescribing and dosing, it would be burdensome and unnecessary to require detailed written consent for every genetic test. At the present time, there is inadequate evidence of the need for legislation prohibiting any genetic test in the absence of a physician’s order. Anonymous HIV and HCV testing using home test collection kits have been used successfully, and already-available home-collection genetic test kits should not necessarily be prohibited at this time. For a further discussion, see generally Gail H. Javitt, Erica Stanley & Kathy Hudson, Direct-to-Consumer Genetic Tests, Government Oversight, and the First Amendment: What the Government Can (and Can’t) Do to Protect the Public’s Health, 57 Okla. L. Rev. 251 (2004).
- 239.For additional recommendations on genetic testing of children to determine parentage, see Rothstein Mark A. Translating Values and Interests into the Law of Parentage Determination. In: Rothstein Mark A, et al., editors. Genetic Ties and the Family: The Impact of Paternity Testing on Parents and Children. Vol. 213. 2005. .
- 240.Such solicitation is prohibited by the U.K.’s Human Tissue Act. See supra notes 187–97 and accompanying text. Unfortunately, there is the obvious problem of regulating off-shore testing laboratories advertising on the Internet. The availability of remedies to deal with this problem is beyond the scope of this Article.
- 241.It should be noted that mailing lists of people with various diseases, including genetic diseases, are commonly sold today. See, e.g., ListFinder, http://listfinder.directmag.com/market?page=research/datacard&id=100590 (providing search results for various types of mailing lists) (last visited Nov. 10, 2008). A discussion of whether such marketing activities should be prohibited is beyond the scope of this Article.
- 242.Additional exemptions might need to be included. For example, it should not be unlawful to sell the analysis of the DNA derived from human remains hundreds or thousands of years old.
- 243.Gattaca (Columbia Pictures 1997).
- 244.Id.
- 245.Id.
- 246.One popular Internet-based company, 23andMe, promises results within six weeks of sample submission for only $399. 23andMe, http://www.23andme.com/store/ (last visited Nov. 5, 2008). 23andMe cut its price from $999 to $399 in September 2008, whereas other leading companies, Navigenics and deCODE genetics, reportedly charge about $2,500 and $1,000, respectively. Andrew Pollack, DNA Profile Provider Is Cutting Its Prices, N.Y. Times, Sept. 9, 2008, at C3. These companies also reportedly have held cocktail parties in which all of the guests produce samples for testing. Allen Salkin, When in Doubt, Spit It Out, N.Y. Times, Sept. 14, 2008, at ST-2.
- 247.23andMe, What is the difference between genotyping and sequencing?, http://www.23andme.com/you/faqwin/sequencing/ (last visited Nov. 5, 2008).
- 248.See Feero WGregory, Guttmacher Alan E, Collins Francis S. The Genome Gets Personal—Almost. 299 JAMA. 2008;1351:1351. doi: 10.1001/jama.299.11.1351. (“[T]he ability to interpret … DNA … still requires a great deal of intense research effort.”).
- 249.See generally Mark A. Rothstein, Keeping Your Genes Private, Sci. Am., Sept. 2008, at 64.
- 250.Id. at 67.
- 251.The Privacy Rule applies only to the following three classes of covered entities: health care providers, health plans, and health care clearinghouses. 45 C.F.R. § 160.102(a) (2008). For a discussion about possibly increasing coverage in schools, see Letter from Simon Cohn, Chairman, National Committee on Vital and Health Statistics, to Michael O. Leavitt, Secretary of Health and Human Services (June 21, 2007), available at http://www.ncvhs.hhs.gov/pvcmemb.htm (June 21, 2007 Letter on update to privacy laws and regulations required to accommodate NHIN data sharing practices).
- 252.See Sharona Hoffman & Andy Podgurski, In Sickness, Health, & Cyberspace: Protecting the Security of Electronic Health Information, 48 B.C. L. Rev. 331, 344 (2007); Ilene N. Moore et al., Confidentiality and Privacy in Health Care from the Patient’s Perspective: Does HIPAA Help?, 17 Health Matrix 215, 229–30 (2007); Nicolas P. Terry & Leslie P. Francis, Ensuring the Privacy and Confidentiality of Electronic Health Records, 2007 U. Ill. L. Rev. 681, 699–700 (2007); Richard Sobel, The HIPAA Paradox: The Privacy Rule That’s Not, Hastings Ctr. Rep. no. 4, at 40 (2007).
- 253.Kendra Gray, The Privacy Rule: Are We Being Deceived?, 11 DePaul J. Health Care L. 2008;89:103–09.. From the Privacy Rule’s compliance date of April 14, 2003, through July 31, 2008, the Office for Civil Rights of the Department of Health and Human Services had received 38,024 complaints. Office for Civil Rights, Dep’t of Health and Human Servs., http://www.hhs.gov/ocr/privacy/enforcement/numbersglance0708.html#all last visited Nov. 10, 2008. Civil monetary penalties, as provided for in the Privacy Rule, had not been assessed in a single case, although on July 15, 2008, the Office for Civil Rights announced that a covered entity had signed a Corrective Action Plan with the government, including a $100,000 payment. Office for Civil Rights, Dep’t of Health and Human Servs., HHS, Providence Health & Services Agree on Corrective Action Plan to Protect Health Information, July 17, 2008, http://www.hhs.gov/news/press/2008pres/07/20080717a.html
- 254.Rothstein, Putting the Genetic Information Nondiscrimination Act in Context, supra note 173, at 655.
- 255.In eleven states, the consent must be in writing. See supra note 152 (list of states, excluding Florida). In one other state, consent must merely be express. Fla. Stat. Ann. § 760.40 (2008).
- 256.See supra note 205 and accompanying text.
- 257.45 C.F.R. §§ 160.102, 164.104 (2007).